CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Raises Price Target on Mirum Pharmaceuticals to $155 From $135, Keeps Outperform Rating

Positive
AI Analysis

Summary

RBC Capital Markets raised its price target on Mirum Pharmaceuticals from $135 to $155 while maintaining an Outperform rating.

Importance:2/10
Sentiment:
0.60
analyst_upgradeprice_target_increaserating_maintained
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 11:45 AM

Read Original